Literature DB >> 29960211

"Sleep disordered breathing and ECG R-wave to radial artery pulse delay, The Multi-Ethnic Study of Atherosclerosis".

Younghoon Kwon1, David R Jacobs2, Pamela L Lutsey2, Lyndia Brumback3, Julio A Chirinos4, Sara Mariani5, Susan Redline5, Daniel A Duprez2.   

Abstract

BACKGROUND: Electrocardiography R-wave to radial artery pulse delay (RRD) represents pulse transit time inclusive of pre-ejection period (PEP) and arterial pulse propagation time. RRD is proposed to largely reflect arterial stiffness when PEP is accounted for (shorter RRD = higher arterial stiffness). Sleep disordered breathing (SDB) causes intermittent hypoxemia and sympathetic activation, which negatively influences vascular function. We aimed to examine the association of measures of SDB with RRD.
METHODS: Our sample consisted of participants in the Multi-Ethnic Study of Atherosclerosis without prevalent cardiovascular disease who underwent a daytime arterial elasticity exam, cardiac magnetic resonance imaging (MRI), and overnight polysomnography. SDB measures of interest included apnea hypopnea index (AHI) and oxygen desaturation index (ODI) (N = 1173). RRD was regressed on each measure of SDB separately, with adjustment for other cardiovascular risk factors as well as for correlates of the PEP, another component of RRD, by including cardiac MRI measures of contractility and preload.
RESULTS: In multivariate analysis, among measures of SDB, ODI, a marker of intermittent hypoxemia, was inversely associated with RRD (β = -60.2 msec per SD [15.5/hr], p = 0.04). No significant association was found with AHI. In gender stratified analyses, ODI and AHI were predictive of RRD in men only (β = -111.3 msec per SD [15.5/hr], p = 0.01 and β = -100.3 msec per SD [16.1/hr], p = 0.02 respectively).
CONCLUSION: Severity of SDB as measured by ODI was associated with RRD, a marker of arterial stiffness. Thus, association of RRD with measures of SDB appears to be gender-dependent.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arterial stiffness; Pulse transit time; Sleep apnea; Sleep disordered breathing

Mesh:

Year:  2018        PMID: 29960211      PMCID: PMC6051731          DOI: 10.1016/j.sleep.2018.05.005

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  42 in total

Review 1.  Is obstructive sleep apnoea causally related to arterial stiffness? A critical review of the experimental evidence.

Authors:  Craig L Phillips; Mark Butlin; Keith K Wong; Alberto P Avolio
Journal:  Sleep Med Rev       Date:  2012-06-01       Impact factor: 11.609

2.  Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study.

Authors:  Susan Redline; Gayane Yenokyan; Daniel J Gottlieb; Eyal Shahar; George T O'Connor; Helaine E Resnick; Marie Diener-West; Mark H Sanders; Philip A Wolf; Estella M Geraghty; Tauqeer Ali; Michael Lebowitz; Naresh M Punjabi
Journal:  Am J Respir Crit Care Med       Date:  2010-03-25       Impact factor: 21.405

3.  The effects of sleep-disordered breathing on arterial stiffness are modulated by age.

Authors:  Claudia E Korcarz; Adam D Gepner; Paul E Peppard; Terry B Young; James H Stein
Journal:  Sleep       Date:  2010-08       Impact factor: 5.849

4.  Aortic-radial pulse transit time and ECG Q-wave to radial pulse wave interval as indices of beat-by-beat blood pressure change.

Authors:  M H Pollak; P A Obrist
Journal:  Psychophysiology       Date:  1983-01       Impact factor: 4.016

5.  Obstructive sleep apnea and aging effects on macrovascular and microcirculatory function.

Authors:  Susie Yim-Yeh; Shilpa Rahangdale; Anh Tu Duy Nguyen; Amy S Jordan; Victor Novack; Aristidis Veves; Atul Malhotra
Journal:  Sleep       Date:  2010-09       Impact factor: 5.849

6.  Pulse transit time changes in subjects exhibiting sleep disordered breathing.

Authors:  Biswajit Chakrabarti; Stephen Emegbo; Sonya Craig; Nick Duffy; John O'Reilly
Journal:  Respir Med       Date:  2016-11-21       Impact factor: 3.415

7.  Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity.

Authors:  Shunsuke Natori; Shenghan Lai; J Paul Finn; Antoinette S Gomes; W Gregory Hundley; Michael Jerosch-Herold; Gregory Pearson; Shantanu Sinha; Andrew Arai; Joao A C Lima; David A Bluemke
Journal:  AJR Am J Roentgenol       Date:  2006-06       Impact factor: 3.959

8.  Endothelin-1 mediates intermittent hypoxia-induced inflammatory vascular remodeling through HIF-1 activation.

Authors:  Emmanuelle Gras; Elise Belaidi; Anne Briançon-Marjollet; Jean-Louis Pépin; Claire Arnaud; Diane Godin-Ribuot
Journal:  J Appl Physiol (1985)       Date:  2015-12-17

9.  Intermittent hypoxia-induced sensitization of central chemoreceptors contributes to sympathetic nerve activity during late expiration in rats.

Authors:  Yaroslav I Molkov; Daniel B Zoccal; Davi J A Moraes; Julian F R Paton; Benedito H Machado; Ilya A Rybak
Journal:  J Neurophysiol       Date:  2011-04-06       Impact factor: 2.714

Review 10.  Chronic intermittent hypoxia and obstructive sleep apnea: an experimental and clinical approach.

Authors:  Emilia Sforza; Fréderic Roche
Journal:  Hypoxia (Auckl)       Date:  2016-04-27
View more
  2 in total

1.  Pulse arrival time, a novel sleep cardiovascular marker: the multi-ethnic study of atherosclerosis.

Authors:  Younghoon Kwon; Christopher Wiles; B Eugene Parker; Brian R Clark; Min-Woong Sohn; Sara Mariani; Jin-Oh Hahn; David R Jacobs; James H Stein; Joao Lima; Vishesh Kapur; Andrew Wellman; Susan Redline; Ali Azarbarzin
Journal:  Thorax       Date:  2021-04-16       Impact factor: 9.102

2.  Inhibition of Vascular Endothelial Cadherin Cleavage Prevents Elastic Fiber Alterations and Atherosclerosis Induced by Intermittent Hypoxia in the Mouse Aorta.

Authors:  Olfa Harki; Sophie Bouyon; Marine Sallé; Alejandro Arco-Hierves; Emeline Lemarié; Alexandra Demory; Carole Chirica; Isabelle Vilgrain; Jean-Louis Pépin; Gilles Faury; Anne Briançon-Marjollet
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.